SC 13G

Company

Traws Pharma, Inc.

Filed

August 18, 2016

Accession Number

0000905718-16-001634

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →